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INTRODUCTION
Hepatocellular carcinoma (HCC) is one of the most
common malignancies worldwide. In Korea, HCC is the
third most common primary malignant tumor and the
third leading cause of death in patients with cancer [1].
Spontaneous rupture of HCC is an uncommon, but fatal
complication leading to immediate death, and especially
for those patients with liver cirrhosis and who may have
coagulation deficiencies. The incidence of spontaneous
HCC rupture is different according to the geographical
area, and it tends to be higher in areas with endemic viral
hepatitis B or C, such as Korea [2-4]. 
In general, the diagnosis of ruptured HCC is based on
the findings of ultrasound or CT, and on the presence of
bloody ascites as ascertained by performing abdominal
paracentesis. Regarding to the management for ruptured
HCC, various treatment options, including hepatic resec-
tion, hepatic artery ligation and transcatheter arterial
embolization (TAE), have been proposed in accordance
with the situation/state the patient is in. When hypo-
volemic shock occurs due to massive intraperitoneal hem-
orrhage, immediate management such as resuscitation for
hypovolemic shock followed by hemostasis is required
before considering a proper treatment for the underlying
HCC. Although hepatic resection is known to be the most
effective treatment for ruptured HCC, the mortality rate
for emergency operations in the ruptured patients with
hepatic decompensation or hypovolemic shock has been
high. TAE is alternatively considered to reduce the initial
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CASE REPORT
A 57-yr-old woman previously diagnosed with chronic hepatitis B was admitted via the emergency room
because she suddenly developed epigastric pain with abdominal distension. On computed tomography (CT), a
round enhancing mass was found on the left hepatic lobe with ascites in the peritoneal space. Bloody ascites
were found upon tapping the ascites, and this led to the diagnosis of ruptured hepatocellular carcinoma (HCC).
The patient was immediately treated with transcatheter arterial chemoembolization (TACE) including 50 mg of
adriamycin and 10 mL of lipiodol, and then we performed left lateral segmentectomy 20 days later. To prevent
recurrence of HCC by any micrometastasis, the patient subsequently received 8 cycles of adjuvant systemic
chemotherapy (a regimen of epirubicin (50 mg/m
2), cisplatin (60 mg/m
2) and 5-fluorouracil (200 mg/m
2)) at
monthly intervals. After this, the patient has been regularly followed up and she shows no signs of tumor
recurrence 7 years later. This case suggests that surgical resection and subsequent adjuvant systemic
chemotherapy with using an ECF regimen may provide long-term survival for patients ruptured HCC. (Korean J
Intern Med 2009;24:63-67)
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on the proper treatment for the underlying HCC. A
previous study reported the average survival times for
patients treated with emergency resection or with delayed
resection were 12 months and 19 months, respectively [5].
However, HCC recurred in most of the patients treated by
resection [5]. Therefore, an additional therapeutic
modality is needed to treat any and all micro-metastatic
tumor that could exist after ruptured HCC. Herein we
report on a case of ruptured HCC that was treated with
hepatic resection and subsequent chemotherapy, and the
patient continues to enjoy her life 7 years after the
operation. 
CASE REPORT
A 57-yr-old woman was admitted to our hospital
because of sudden-onset abdominal pain. She was a
known chronic HBV carrier. She had no significant
medical history such as diabetes, hypertension or tuber-
culosis; she did not smoke or drink any alcohol. On
admission, she had a blood pressure of 90/60 mmHg, a
105/min pulse rate, a 20/min respiratory rate and a body
temperature of 36.3˚C . On physical examination, the
patient had an acutely ill looking appearance with
abdominal distension and she felt tenderness on the
whole abdomen upon palpation. The laboratory data on
admission showed a white blood cell count of 5,800/mm
3,
a hemoglobin level of 10.8 g/dL, a hematocrit of 30.6%
and a platelet count of 123,000/mm
3. The serum alanine
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Figure 1. Abdominal enhanced CT scan shows a large arterial-phase enhancing mass in the left lobe of the liver, along with ascites (A&B).
Selective hepatic arteriography shows hypervascular tumor stains in the left lobe of the liver (C&D).
A B
C Dtransaminase (ALT) was 72 U/L (normal: 5-40 U/l), the
serum aspartate transaminase (AST) was 122 U/L
(normal: 8-40 IU/L), the total protein 6.5 g/dL, the serum
albumin 3.6 g/dL and the alkaline phosphatase 187 U/L
(normal: 100-250 U/L). The prothrombin time was 100%
(INR, 0.95) and the total bilirubin level was 4.8 mg/dL
(direct bilirubin 1.7 mg/dL). She was positive for HBsAg,
but negative for HBeAg, and the HBV DNA level was less
than 2.5 pg/mL. The level of alpha-fetoprotein (AFP) was
62.3 ng/mL (normal: 0-20 ng/mL). The chest X-ray
showed elevation of the right hemidiaphragm and
abdominal X-ray showed abdominal distension, cen-
tralization and floating of bowel loops and widening of the
interloopal space, which suggested ascites. Abdominal
enhanced computerized tomography (CT) scanning
showed a large arterial-phase enhancing mass in the left
lobe with ascites (Fig. 1A and 1B).
She was immediately treated with transarterial
chemoembolization (TACE) by a regimen of adriamycin
50 mg and lipiodol 10 mL (Fig. 1C and 1D). We performed
left lateral segmentectomy twenty days after the TACE
(Fig. 2A and 2B). One month after the hepatic surgery, to
prevent recurrence of HCC by micro-metastasis, the
patient subsequently received 8 cycles of adjuvant
systemic chemotherapy by a regimen of epirubicin (50
mg/m
2), cisplatin (60 mg/m
2) and 5-fluorouracil (5-FU,
200 mg/m
2) at monthly intervals. After this, patient has
been regularly followed up to date and she shows no signs
of tumor recurrence 7 years later (Fig. 3). This case
suggests that surgical resection and subsequent adjuvant
systemic chemotherapy using an ECF regimen may
provide long-term survival for patients with ruptured
HCC.
DISCUSSION
The ruptured HCC is a life threatening condition that
may cause severe bleeding, hypotension and hypoper-
fusion of the liver, especially in cirrhotic patients who have
coagulation deficiencies. Therefore, the mortality for this
catastrophic event is very high, and early diagnosis of the
ruptured HCC is essential to prolong the survival of these
patients. The most characteristic finding of ruptured HCC
is reported to be the sudden-onset of abdominal pain [6]
and a physician, when observing such symptoms in
geographic areas that are endemic for hepatitis viruses,
can have a strong suspicion of ruptured HCC. 
The mechanism of HCC rupture is poorly understood.
However, several factors such as direct trauma, high intra-
luminal pressure due to rapid growth of tumor, necrosis,
rupture by splitting of the normal hepatic parenchyma or
erosion of a vessel, occlusion of the hepatic veins by tumor
thrombus, and coagulopathy have been accepted as
causes [7,8]. In general, tumors that protrude beyond the
original liver contour may rupture more readily than those
that are surrounded by normal parenychma [9].
Furthermore, a peripheral location and protrusion of the
tumor or discontinuity of the hepatic surface, and poor
liver function should be recognized as high risk factors for
HCC rupture. However, the TMN stage, the presence of
portal vein thrombosis and the size of the tumor seem to
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Figure 2. Liver Biopsy. (A) The liver shows mixed micro-macronodular cirrhosis with foci of micro-and macrovesicular steatosis (H&E, original
magnification ×40). (B) The liver specimen shows a grade ll hepatocellular carcinoma, according to the criteria of Edmondson- Steiner. The tumor
cells have abundant cytoplasm, and the cells are polygonal in shape. There are predominate nuclei and nucleoli (H&E, original magnification ×400).
A Bbe irrelevant to HCC rupture [10]. Rupture of HCC is
confirmed by performing abdominal paracentesis, and the
fluid shows blood-stained ascites. However, an imaging
study such as ultrasonography or CT can demonstrate the
extent of blood loss, the severity of the liver cirrhosis, the
location of the tumor and the patency of the portal vein [11]. 
The primary purpose of treatment for ruptured HCC is
to stabilize the hypovolemic shock that’s due to massive
hemorrhage. Next, the treatment of the underlying HCC
using various modalities, including hepatic resection or
TAE, should be considered. Yet the feasibility of per-
forming hepatic resection is dependent on the hepatic
reserve and the underlying liver cirrhosis. Previous studies
have demonstrated that the resectability rates of ruptured
HCC patients ranged from 12.5% to 59.3% [6,12]. In
addition, the survival rate was greater in the delayed
resection group compared to the emergency resection
group (19 months vs. 12 months, respectively) [5]. However,
the longest survival in the emergency group was 33
months and this was 27 months in the delayed resection
group [5]. In this regard, delayed resection seems to
improve the short-term survival, but the long-term
survival remains questionable. In the present case, the
patient immediately received TACE after the diagnosis of
ruptured HCC, and this was followed by left lateral
segmentectomy. Although the efficacy of chemotherapy
for HCC is still debatable, our previous study showed a
significant anti-tumor effect in selected patients with HCC
[13]. Based on this result and with the hope of preventing
HCC recurrence, we treated the lady with 8 cycles of
adjuvant systemic chemotherapy by a regimen of
epirubicin, cisplatin and 5-fluorouracil at monthly
intervals. After this, the patient has been regularly
followed up to date and she shows no signs of tumor
recurrence 7 years later. Few cases have been reported in
the medical literature for which the patients lived 7 years
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Figure 3. CT findings during the follow up period after surgical resection of the left lobe and the subsequent chemotherapy. There is no
evidence of tumor recurrence on the arterial (A) and portal phase (B) of the dynamic CT scan that was done 1 month after the operation. Seven
and a half years after the initial treatment, the arterial (C) and portal phase (D) images show no abnormal tumor staining.
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C Dor more after experiencing ruptured HCC, such as our
patient has done. The reason why our patient has survived
for such a long time without recurrence of HCC may be
attributed to the adjuvant chemotherapy we aggressively
administered after surgical resection. In addition, her
good liver function and lower viral load may have con-
tributed to the good prognosis. It is essential that the
chosen treatment be tailored to a ruptured HCC patient’s
individual needs to prolong the survival time. In sum-
mary, performing surgical resection and subsequently
adjuvant systemic combination chemotherapy may
provide a fighting chance for patients with ruptured HCC
to achieve long-term survival. 
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